Short Interest in Masimo Co. (NASDAQ:MASI) Decreases By 20.6%

Masimo Co. (NASDAQ:MASI - Get Free Report) was the target of a significant decline in short interest in December. As of December 31st, there was short interest totalling 2,740,000 shares, a decline of 20.6% from the December 15th total of 3,450,000 shares. Currently, 5.6% of the shares of the stock are short sold. Based on an average daily volume of 561,600 shares, the short-interest ratio is currently 4.9 days.

Masimo Trading Up 3.6 %

NASDAQ:MASI traded up $5.98 on Wednesday, hitting $172.07. The stock had a trading volume of 722,973 shares, compared to its average volume of 484,541. The company has a quick ratio of 1.11, a current ratio of 2.01 and a debt-to-equity ratio of 0.50. The stock has a market cap of $9.21 billion, a price-to-earnings ratio of 118.67 and a beta of 1.01. The company has a fifty day moving average price of $168.77 and a two-hundred day moving average price of $139.31. Masimo has a 1-year low of $101.61 and a 1-year high of $180.97.

Masimo (NASDAQ:MASI - Get Free Report) last posted its earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.14. The company had revenue of $504.60 million for the quarter, compared to analyst estimates of $502.87 million. Masimo had a net margin of 3.85% and a return on equity of 14.98%. Masimo's revenue was up 5.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.63 EPS. Equities research analysts expect that Masimo will post 4.03 earnings per share for the current fiscal year.

Analysts Set New Price Targets

MASI has been the subject of a number of research reports. BTIG Research boosted their target price on shares of Masimo from $166.00 to $170.00 and gave the stock a "buy" rating in a research note on Monday, October 14th. Raymond James boosted their price target on shares of Masimo from $170.00 to $194.00 and gave the stock an "outperform" rating in a research report on Friday, December 27th. Piper Sandler boosted their price target on shares of Masimo from $180.00 to $210.00 and gave the stock an "overweight" rating in a research report on Wednesday, December 18th. Wells Fargo & Company boosted their price target on shares of Masimo from $171.00 to $193.00 and gave the stock an "overweight" rating in a research report on Wednesday, December 11th. Finally, Needham & Company LLC restated a "hold" rating on shares of Masimo in a research report on Wednesday, November 6th. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Masimo presently has an average rating of "Moderate Buy" and a consensus price target of $179.67.

Hedge Funds Weigh In On Masimo

Several large investors have recently made changes to their positions in MASI. FMR LLC lifted its holdings in shares of Masimo by 41.2% in the 3rd quarter. FMR LLC now owns 6,756,618 shares of the medical equipment provider's stock worth $900,860,000 after acquiring an additional 1,970,883 shares during the last quarter. Thrivent Financial for Lutherans lifted its holdings in shares of Masimo by 42.1% in the 2nd quarter. Thrivent Financial for Lutherans now owns 1,217,357 shares of the medical equipment provider's stock worth $153,314,000 after acquiring an additional 360,497 shares during the last quarter. Point72 Asset Management L.P. lifted its holdings in shares of Masimo by 107.8% in the 2nd quarter. Point72 Asset Management L.P. now owns 677,677 shares of the medical equipment provider's stock worth $85,347,000 after acquiring an additional 351,523 shares during the last quarter. Westfield Capital Management Co. LP lifted its holdings in shares of Masimo by 23.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,394,056 shares of the medical equipment provider's stock worth $185,869,000 after acquiring an additional 262,370 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its holdings in shares of Masimo by 916.1% in the 4th quarter. Assenagon Asset Management S.A. now owns 216,051 shares of the medical equipment provider's stock worth $35,713,000 after acquiring an additional 194,788 shares during the last quarter. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.